International Journal of Gynecological Cancer

Article	Citations
Effect of Substantial Lymphovascular Space Invasion on Location of First Disease Recurrence in Surgical Stage I Endometrioid Endometrial Adenocarcinoma	118
Liquid biopsy for diagnosing epithelial ovarian cancer: quantification of cell-free DNA and p53 mutational analysis	107
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study	97
Minimally invasive surgery for simple hysterectomy in early-stage cervical cancer: ‘SHAPing’ a path forward	80
Computed tomography–based prediction of interval cytoreduction in advanced ovarian cancer	68
Performance of molecular classification in predicting oncologic outcomes of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer	68
Correspondence on “Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer the prospective (PROME) trial” by Bogani et al	64
Prognosis of stage-I ovarian mucinous tumors according to expansile and infiltrative types	62
Surgical approach of the left upper quadrant for ovarian cancer in 10 steps	59
Correspondence on ‘Enhanced recovery after surgery in gynecologic oncology: time to address barriers to implementation in low- and middle-income countries’ by Nelson et al	53
Cervical cancer in pregnancy at various gestational ages	50
Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management	49
The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries	47
Ovarian yolk sac tumor	46
Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study)	44
Recurrence of vulvar squamous cell carcinoma as an undifferentiated sarcomatoid carcinoma	41
Primary vaginal sarcoma treated with upfront fertility-sparing surgery	40
Correction: Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series	35
Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix	32
Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation	31
Does obesity influence the preferred treatment approach for early-stage cervical cancer? A cost-effectiveness analysis	30
Imaging to optimize gynecological radiation oncology	29
The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review	29
Management of stage III and IVa uterine cancer	28
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups	27

Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis	25
Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty	25
Minimally invasive secondary cytoreductive surgery for hepato-renal recess isolated recurrence of serous endometrial cancer in BRCA1 mutated patient	25
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study	25
Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial)	24
Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry	24
Metabolic profile of patients with endometrial adenocarcinoma and association with tumor grade	24
Sentinel lymph node mapping in early-stage ovarian cancer: surgical technique in 10 steps	23
Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study	22
Four protective maneuvers in minimal invasive surgery of endometrial cancer	21
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation	20
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer	20
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance	20
Superior and inferior hypogastric plexus	20
Surgical and oncological outcomes of sentinel lymph node sampling in elderly patients with intermediate to high-risk endometrial carcinoma	20
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy	19
Retreatment with progestin for recurrence after complete response with fertility-sparing treatment in patients with endometrial cancer	19
Are endometrial cancer clinical practice management guidelines sufficiently consumer centric?	19
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer	18
In memoriam—Charles Paul Morrow, MD	17
Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States	17
Outcomes and endpoints of relevance in gynecologic cancer clinical trials	17
Management of refractory chylous ascites: a challenge after lymphadenectomy	16
Transumbilical laparoendoscopic single-site radical trachelectomy with uterine arteries’ ascending branches preservation for early-stage cervical cancer	16
New therapies for clear cell ovarian carcinoma	16
Surgical technique and surgeon volume: the pursuit of data-driven outcomes	15
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’	15
Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer	15
Correction: The increasing incidence of stage IV cervical cancer in the USA: what factors are related?	14
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients	14
Update in the molecular classification of endometrial carcinoma	14
Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab	14
Chemotherapy-free treatment of recurrent advanced ovarian cancer: myth or reality?	14
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer	14
Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause	14
Safety and activity of anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose	13
Correspondence on ‘Inside the war: life in Ukraine’ by Shushkevich	13
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report	13
Perioperative ovarian cancer guidelines: prevention and management of upper abdominal complications	12
In memorium: C Paul Morrow (1935–2022)	12
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research a	12
Best original research presented at the 23rd European Congress on Gynaecological Oncology—Best of ESGO 2022	12
BRCA testing on buccal swab to improve access to healthcare and cancer prevention: a performance evaluation	12
Laparoscopic sentinel lymph node mapping with indocyanine green in endometrial cancer: surgeon’s learning curve (cumulative sum analysis)	12
Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer	12
Gynecologic oncologists in surgery for placenta accreta spectrum: a survey for practice, experience, and interest	12
Intracystic endometrioid borderline tumor	12
Electrochemotherapy with intravenous bleomycin for heavily pre-treated vulvar cancer patients	12
Ectopic mammary tissue of the vulva	11
Growing teratoma syndrome	11

Context-dependent environmental associations with endometrial cancer histotype and genotype	11
Can we improve survival with less overall morbidity for patients with intermediate-risk cervical cancer without the use of external beam radiotherapy?	11
Improvement in radiation techniques for locally advanced cervical cancer during the last two decades	11
Unusual abdominal clear cell carcinoma	11
Inflammatory myofibroblastic tumor: a rare uterine mesenchymal neoplasm	11
Artificial intelligence and visual inspection in cervical cancer screening	11
Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancer	11
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma	11
Trends and current aspects of reconstructive surgery for gynecological cancers	11
Scalp recurrence of uterine leiomyosarcoma	11
Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers	11
Laparoscopic posterior pelvic exenteration using the abdominal perineal resection (APR) technique for management of tumor invading both vagina and rectum	10
Tumor biology and impact on timing of surgery in advanced epithelial ovarian cancer	10
Well-differentiated papillary mesothelial tumor of the peritoneum	10
Latin American video workshop: a new strategy to learn surgery in gynecology oncology	10
Change of Fagotti score is associated with outcome after neoadjuvant chemotherapy for ovarian cancer	10
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers	9
Characterization of pre-operative anemia in patients undergoing surgery by a gynecologic oncologist and association with post-operative complications	9
MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?	9
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer	9
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationa	9
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer	9
How to break bad news and how to learn this skill: results from an international North-Eastern German Society for Gynecological Oncology (NOGGO) survey among physicians and medical students with 1089	9
Uterine leiomyoma with bizarre nuclei	9
Correction: MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?	9
Adherence to ESGO guidelines and impact on survival in obese patients with endometrial cancer: a multicentric retrospective study	9
Sentinel lymph node mapping with indocyanine green using SPY-PHI in open radical hysterectomy or trachelectomy	8
Alternatives of the pelvic sentinel lymph node migration pathway in early ovarian cancer: the simplest the best	8
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients	8
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series	8
Inguinofemoral lymphadenectomy technique in 10 steps	8
Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework	8
Major determinants of survival in recurrent endometrial cancer—the role of secondary cytoreductive surgery: a multicenter study	8
Human papillomavirus genotyping for predicting disease progression in women with biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade intraepithelial lesion cytology	8
Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an o	7
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico	7
Gynecologic Oncology at Home: a new opportunity to teach and learn	7
Health-related quality of life metrics as endpoints in surgical trials: hype or hope?	7
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion	7
Durable response in platinum refractory small cell carcinoma of the ovary hypercalcemic type treated with combination pembrolizumab, oral cyclophosphamide, and bevacizumab	7
Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese)	7
MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer	7
Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer	7
Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries	7
Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer	7
Mirvetuximab soravtansine: an oasis in the desert?	7
Prognostic value of molecular classification in stage IV endometrial cancer	7
Uterine fundus indocyanine green injection for sentinel lymph node biopsy in endometrial cancer patients with limited access to cervical injection	7
Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis	7
Ectopic ovary in BRCA 1 muted patient	7
Response to: Correspondence on “Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods” by Lavoue et al	7
Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer	7
Cancer statistics, 2024: mixed results in gynecologic oncology	7
The early history of the International Gynecologic Cancer Society (IGCS)	6
UTERUS 11 is a negative trial	6
Surveillance imaging for salvage therapy in endometrial cancer	6
Vulvar cancer resection with V–Y advancement flap reconstruction	6
Ultrasound of malignant uterine mass: degenerative versus necrotic cystic manifestations and lack of structure	6
Pegylated liposomal doxorubicin combined with trabectedin as a treatment option in uterine sarcomas: a single-institution retrospective analysis	6
ENYGO-IJGC scientific writing and publication course: 2021 meeting summary	6
Evaluating the use of machine learning in endometrial cancer: a systematic review	6
Gastrointestinal stromal tumor: a rare case of ovarian involvement	6
Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study	6
Secondary cytoreductive surgery for recurrent endometrial cancer: can we predict the future?	6
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gyn	6
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or	6
Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes	6
Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies	6
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024	6
Risk factors for vaginal squamous intra-epithelial lesions in women with high-grade cervical lesions	6
Cervical cancer and risk of dementia: real-world insights from a nationwide cohort study in Taiwan	6
Treatment of hydatidiform mole using manual vacuum aspiration: technical and tactical aspects	5
Primary ovarian lymphoma	5
Ectopic left renal artery originating from the left common iliac artery: a rare anatomic variation	5
Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis	5
Human papillomavirus-independent cervical cancer: what are the implications?	5
Low-volume lymphatic metastasis (isolated tumor cells) in endometrial cancer: management and prognosis	5
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial	5
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission	5
Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3	5

Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer	5
In Memoriam: John J. Kavanagh (1947-2021)	5
Placental site trophoblastic tumor versus exaggerated placental site: a diagnostic dilemma	5
Right upper quadrant peritonectomy. Answering frequently asked questions	5
The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanoma	5
Human papillomavirus-independent cervical cancer	5
Importance of stress management in gynecological cancer	5
Laparoscopic approach to paravaginal low-grade sarcoma	5
Call for emergency action to limit global temperature increases, restore biodiversity and protect health	5
Three-dimensional computed tomography reconstruction of the para-aortic area in a patient with infrarenal vena cava agenesis	5
Practice patterns in post-treatment surveillance in patients with primary epithelial ovarian cancer	5
Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis	5
Oncovascular surgery: is it time for a step forward in gynecologic oncology surgery?	5
Correction: Improving response to progestin treatment of low-grade endometrial cancer	5
Prophylactic subcutaneous retention sutures in the prevention of superficial wound separation of midline laparotomy	5
Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULCANize2)	5
Gynecologic oncology fellowship in Indonesia	5
Correspondence on "European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery" by Fotopoulou et al	5
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer	5
Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy	5
Atypical polypoid adenomyoma	5
Safety and management of niraparib monotherapy in ovarian cancer clinical trials	4
Impact of enhanced recovery after surgery (ERAS) programs in the return to adjuvant chemotherapy in patients with advanced ovarian cancer	4
Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis	4
Oncovascular surgery in gynecologic oncology: en bloc metastatic lymph node and infiltrated inferior vena cava resection followed by patch reconstruction	4
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)	4
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma	4
Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outco	4
Secondary malignancies in long-term ovarian cancer survivors: results of the ‘Carolin meets HANNA’ study	4
Loop colostomy formation with a skin bridge technique in a gynecological oncology center	4
Video-endoscopic inguinal sentinel lymph node biopsy with indocyanine green in vulvar cancer	4
Should the cut-off for concomitant radiochemotherapy and intracavitary 3D adaptive uterovaginal brachytherapy be 3 cm?	4
Hepatic hilum cytoreductive surgery for ovarian cancer relapse	4
Multidisciplinary management of placenta accreta spectrum in Lebanon: a model for improving outcomes	4
Exploring cervical cancer mortality in Brazil: an ecological study on socioeconomic and healthcare factors	4
Imaging modalities in fertility preservation in patients with gynecologic cancers	4
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery	4
Ultrasonographic diagnosis in rare primary cervical cancer	4
Efficacy of pre-operative pharmacologic thromboprophylaxis on incidence of venous thromboembolism following major gynecologic and gynecologic oncology surgery: a systematic review and meta-analysis	4
Use of social media for academic and professional purposes by gynecologic oncologists	4
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma—a multicenter, single-arm, phase II, clinical proof-of-concept study	4
Use of Quadratus Lumborum Block in Gynecologic Procedures	4
Two possible entities of endometriosis-associated ovarian cancer: correlated or incidental?	4
A cost-effectiveness analysis of sentinel lymph node biopsy compared with lymphadenectomy in intermediate- and high-risk endometrial carcinoma	4
Immature teratoma of the ovary	4
Response to: Correspondence on “Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation” by Gorostidi	4
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins	4
Uterine transposition after radical trachelectomy	4
First robotic radical trachelectomy for cervical cancer using the Hugo RAS platform	4
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy	4
Many ways, one destination: a comprehensive review of screening and assessment tools to detect malnutrition in patients with ovarian cancer	3
Fertility-sparing surgery for growing teratoma syndrome: a case of complete cytoreductive surgery with a colo-rectal re-section	3
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets	3
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)	3
Complex abdominal wall reconstruction for an isolated parietal recurrence of ovarian cancer	3
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators	3
Isolated tumor cells in low-risk endometrial cancer: are we ready for treatment decisions in ‘isolation’?	3
PARSGO and UM6SS: spearheading excellence in gynecological oncology in Morocco	3
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting	3
How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer	3
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study	3
Ovarian-stimulating drug use and risk of ovarian tumor in infertile women: a meta-analysis	3
Factors Influencing Surgeons' Decision for Diverting Ileostomy and Associated Complications in Ovarian Cancer Cytoreductive Surgery	3
Reviews covering publications from September 30, 2022–March 31, 2023	3
Minimally invasive anterior pelvic exenteration with partial bladder preservation: a step-by-step technique demonstration	3
Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis	3
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy	3
Comparison of overall and patterns of care in patients with a malignant ovarian germ cell tumor by age in the United States: a National Cancer Database (2004–2016) analysis	3
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry	3
FDA approves the first HPV self-collection solutions	3
Association of clinical and laboratory variables with risk of venous thromboembolism in high-grade serous ovarian cancer	3
Social media ambassadors and collaboration with OncoAlert: a European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022	3
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	3
Role of V-Y flap reconstruction in vulvar cancer patients: multicenter retrospective study	3
Updates and Controversies in the Management of Uterine Serous Carcinoma and Uterine Carcinosarcoma	3
Patient-initiated follow-up in low-risk endometrial cancer after surgery: a systematic review	3
Progression-free survival as a potential surrogate end point for overall survival in advanced cervical carcinoma	3
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study	3
Role of pre-sacral sentinel lymph nodes in endometrium and cervical cancer: experience with minimally invasive indocyanine green sentinel lymph node mapping	3
DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding	3
Incidence of pre-neoplastic and neoplastic lesions of the cervix before and after the COVID-19 pandemic	3
Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study	3
Total uterine inversion due to pedunculated vaginal tumor	3
Preoperative prediction model of lymph node metastasis in the inguinal and femoral region based on radiomics and artificial intelligence	3
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care	3
Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer	3
Vulvar and clitoral reconstruction using bilateral Singapore island perforator flap after anterior vulvectomy	3
Non-invasive mediastinal lymph node metastasis of serous borderline ovarian tumor	3
Correspondence on “Fertility-sparing treatment with conization versus radical hysterectomy in patients with early-stage cervical cancer: inverse propensity score weighted analysis,” by Ditto et al	3
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer	2
Imaging modalities in pregnant cancer patients	2
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment follo	2
Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer	2
Carcinosarcoma of the uterine corpus with liposarcomatous differentiation: histopathological characteristics	2
Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation	2